Home/Filings/4/0001104659-20-140595
4//SEC Filing

Stephan Dietrich A 4

Accession 0001104659-20-140595

CIK 0001173281other

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 5:01 PM ET

Size

14.5 KB

Accession

0001104659-20-140595

Insider Transaction Report

Form 4
Period: 2020-12-29
Stephan Dietrich A
DirectorPresident and CEO10% Owner
Transactions
  • Gift

    Common Stock

    2020-12-011,273,8192,547,639 total(indirect: See footnote)
  • Gift

    Common Stock

    2020-11-232,547,6392,547,639 total(indirect: See footnote)
  • Award

    Stock option (right to buy)

    2020-12-29+164,925164,925 total
    Exercise: $6.92Exp: 2030-12-29Common Stock (164,925 underlying)
  • Gift

    Common Stock

    2020-11-301,273,8192,547,639 total(indirect: See footnote)
  • Gift

    Common Stock

    2020-12-011,273,8201,273,819 total(indirect: See footnote)
Holdings
  • Common Stock

    12,525
Footnotes (6)
  • [F1]Shares held by the reporting person as a tenant by the entirety with his spouse.
  • [F2]This transaction involved a gift of securities by the reporting person to a revocable trust in which the reporting person is the grantor, trustee and sole beneficiary.
  • [F3]This transaction involved a gift of securities by the reporting person to a revocable trust in which the spouse of the reporting person is the trustee and sole beneficiary.
  • [F4]This transaction involved a gift of securities by the reporting person to an irrevocable trust in which the spouse of the reporting person is the investment trustee, and the spouse and the descendants of the reporting person are the beneficiaries of such irrevocable trust. It also involved a gift of securities by the reporting person's spouse to an irrevocable trust in which the reporting person is the investment trustee, and the reporting person and the descendants of the reporting person's spouse are the beneficiaries of such irrevocable trust.
  • [F5]These shares are indirectly beneficially owned through the irrevocable trusts described immediately above.
  • [F6]25% of the total shares shall vest on the first anniversary of December 29, 2020, and the remaining shares shall vest on an equal monthly basis over the following 36 months.

Issuer

NeuBase Therapeutics, Inc.

CIK 0001173281

Entity typeother

Related Parties

1
  • filerCIK 0001774588

Filing Metadata

Form type
4
Filed
Dec 29, 7:00 PM ET
Accepted
Dec 30, 5:01 PM ET
Size
14.5 KB